Who is sponsoring NCT06604819?

NCT06604819 is sponsored by Suez Canal University.

What drugs are being tested in NCT06604819?

Interventions in NCT06604819: Ozone gel placed after closed sinus lifting then implant placed simultaneously., closed sinus lifting using osteotomes with simultaneous implant placement.

What condition does NCT06604819 study?

NCT06604819 studies Sinus Pneumatization.

Is NCT06604819 still recruiting?

NCT06604819 is currently completed. Last updated 20 September 2024.

Last reviewed 2024-09-20 · How we verify

NCT06604819

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Impact of Ozone Gel on the Bone Height and Density

Completed NA Last updated 20 September 2024

What this trial tests

NA trial testing Ozone gel placed after closed sinus lifting then implant placed simultaneously. in Sinus Pneumatization in 19 participants. Completed in 20 December 2023.

Timeline

21 December 2021

Primary endpoint
15 December 2022

20 December 2023

Quick facts

Lead sponsor	Suez Canal University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	19
Start date	21 December 2021
Primary completion	15 December 2022
Estimated completion	20 December 2023
Sites	1 location across Egypt

Drugs / interventions tested

Ozone gel placed after closed sinus lifting then implant placed simultaneously. — full drug profile →
closed sinus lifting using osteotomes with simultaneous implant placement

Conditions studied

Sinus Pneumatization — all drugs for Sinus Pneumatization →

Sponsor

Suez Canal University

Who can join

18 and older, any sex, with Sinus Pneumatization. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Purpose: The present study was conducted to evaluate the effect of using ozone gel with maxillary sinus elevation using tenting technique on the clinical and radiographic outcome of implants placed simultaneously.. Materials and Methods: A total of 30 sinuses with an average residual alveolar bone height ranging from 4-7 mm participated in this randomized controlled clinical trial. After closed sinus lift operation, patients were randomly and equally allocated into control group and ozone gel recipient group. Cone beam computed tomography was performed immediately and at 4 months postoperatively. Bone stability was measured immediately and at 3 \& 4 months postoperatively. Bone height and stability were evaluated radiographically, and bone stability was measured using the Osstell device.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Does ozone gel enhance the bone width and buccal plate of bone thickness surrounding the implant following osseodensification? A randomized controlled clinical trial.
Yousry D, Riad R, Soliman RA, ElSholkamy M. · · 2025 · PMID 40229413 · DOI 10.1007/s10006-025-01367-x

Verify or expand the search:

Other recruiting trials for Sinus Pneumatization

Currently open trials in the same condition.

NCT07526129 — Impact of Alveolar Ridge Preservation on the Potential Need for Sinus Floor Elevation: A 10-year Retrospective Radiograp · recruiting

Other Suez Canal University trials

Trials by the same sponsor.

NCT07263893 — Inter Flex Three Dimensional Plate in Management of Mandibular Fracture RCT · NA · recruiting
NCT07280533 — Accuracy of Virtual Surgical Planning Versus Traditional Technique in Zygomaticomaxillary Fracture Reduction · NA · not yet recruiting
NCT07291791 — tDCS for Pain Modulation in Knee Osteoarthritis · NA · active not recruiting
NCT07262086 — Clinical Evaluation of Wear Resistance and Bioactivity of Self Cured Bioactive Resin Composite · NA · enrolling by invitation
NCT07125846 — Efficacy of Bioactive Glass vs. Xenograft in Maxillary Sinus Augmentation · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06604819 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Suez Canal University
Last refreshed: 20 September 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06604819.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing